advertisement
Iwamura R 13
Showing records 1 to 13 |
Display all abstracts from Iwamura R78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive MonkeysFuwa M
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag IsopropylIwamura R; Iwamura R
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive MonkeysToris CB
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag IsopropylTanaka M
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive MonkeysFan S
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag IsopropylOkanari E; Kirihara T
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive MonkeysTaniguchi T
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag IsopropylOdani-Kawabata N
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive MonkeysIchikawa M; Odani-Kawabata N
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag IsopropylShams N
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive MonkeysIwamura R; Iwamura R
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag IsopropylYoneda K
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive MonkeysYoneda K; Matsugi T; Shams NK; Zhang JZ
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
Issue 19-4
Change Issue
advertisement